News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
CYP2C19*2 and CYP2C9*3 Linked to Increased Stent Thrombosis Risk
September 30, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MedWire News -- Dutch researchers report that patients who carry the CYP2C19*2 or CYP2C9*3 loss-of-function alleles have an increased risk for stent thrombosis (ST) after percutaneous coronary intervention (PCI).
Twitter
LinkedIn
Facebook
Email
Print